Ondine Biomedical
bd_0d0ac96514a02b8b · schema v1 · pii pii-v1
Full breach record for Ondine Biomedical →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group INC Ransom on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Ondine Biomedical Inc. is a Canadian headquartered company led by founder and CEO, Carolyn Cross. Ondine has developed a patented, photodisinfection technology platform used in treatment and prevention therapies for a broad-spectrum of pathogens - including multidrug-resistant strains. Photodisinfection, which is not currently approved in the United States We will publish all the information next week.
Source provenance
- Source URL
- https://www.ransomware.live/
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Feb 16, 2026
- Raw hash
- 4d0c6746612bad988eb0c838cc67c712192ff03bd9b613c5e8c14f9affaf838a
Reporting entity
- Name
- incransomnorm: inc_ransom
Victim entity
- Name
- Ondine Biomedicalnorm: ondine biomedical
- Domain
- ondinebio.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· inc_ransom
- Threat actor
- Inc RansomExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.